Vargatef

CAS : 1160294-26-7

Ref. 3D-KWB29426

Informations sur le produit

• Nom: Vargatef
• Synonymes: 2,3-Dihydro-3[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester

Description

Nintedanib is a medicinal inhibitor that targets cancer cells by inhibiting protein kinases. It has been shown to be effective against various types of tumors, including leukemia. Nintedanib exerts its anti-cancer effects by disrupting the cell cycle and inducing apoptosis in tumor cells. This drug has been tested on human cancer cell lines and has shown promising results in inhibiting tumor growth. Additionally, studies have shown that nintedanib can inhibit angiogenesis, which is the formation of new blood vessels that supply nutrients to tumors. This makes it a potential treatment for cancers that rely on angiogenesis for their growth.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 539.6 g/mol
• Formule: C₃₁H₃₃N₅O₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder